This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • FDA approves Rubraca for metastatic castration-res...
News

FDA approves Rubraca for metastatic castration-resistant prostate cancer.- Clovis Oncology

Read time: 1 mins
Last updated:18th May 2020
Published:16th May 2020
Condition: Prostate Cancer
Type: drug
Register now for full access to medthority.com